These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 17332908)

  • 1. In vitro synergy of baicalein and gentamicin against vancomycin-resistant Enterococcus.
    Chang PC; Li HY; Tang HJ; Liu JW; Wang JJ; Chuang YC
    J Microbiol Immunol Infect; 2007 Feb; 40(1):56-61. PubMed ID: 17332908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method.
    Thamlikitkul V
    J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-kill and synergism studies of ceftobiprole against Enterococcus faecalis, including beta-lactamase-producing and vancomycin-resistant isolates.
    Arias CA; Singh KV; Panesso D; Murray BE
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2043-7. PubMed ID: 17438057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seeking vancomycin resistant Staphylococcus aureus among patients with vancomycin-resistant enterococci.
    Franchi D; Climo MW; Wong AH; Edmond MB; Wenzel RP
    Clin Infect Dis; 1999 Dec; 29(6):1566-8. PubMed ID: 10585815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms.
    Sandoe JA; Wysome J; West AP; Heritage J; Wilcox MH
    J Antimicrob Chemother; 2006 Apr; 57(4):767-70. PubMed ID: 16464896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of vancomycin activity by phenothiazines against vancomycin-resistant Enterococcus faecium in vitro.
    Rahbar M; Mehrgan H; Hadji-nejad S
    Basic Clin Pharmacol Toxicol; 2010 Aug; 107(2):676-9. PubMed ID: 20353486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-kill study and synergistic activity of cell-wall inhibitor antibiotics in combination with gentamicin against Enterococcus faecalis and Enterococcus faecium.
    Aligholi M; Emaneini M; Taherikalani M; Shahsavan S; Jabalameli F; Asadollahi P; Khoramian B; Eslampour MA
    Acta Microbiol Immunol Hung; 2011 Sep; 58(3):219-26. PubMed ID: 21983323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum bactericidal activities of high-dose daptomycin with and without coadministration of gentamicin against isolates of Staphylococcus aureus and Enterococcus species.
    DeRyke CA; Sutherland C; Zhang B; Nicolau DP; Kuti JL
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3529-34. PubMed ID: 17065618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci.
    Rand KH; Houck H
    J Antimicrob Chemother; 2004 Mar; 53(3):530-2. PubMed ID: 14963062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial activity of phytochemicals isolated from Erythrina zeyheri against vancomycin-resistant enterococci and their combinations with vancomycin.
    Sato M; Tanaka H; Oh-Uchi T; Fukai T; Etoh H; Yamaguchi R
    Phytother Res; 2004 Nov; 18(11):906-10. PubMed ID: 15597305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
    Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.
    Wang Z; Cao B; Liu YM; Gu L; Wang C
    Chin Med J (Engl); 2009 Jun; 122(11):1283-8. PubMed ID: 19567138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Cha R
    Pharmacotherapy; 2008 Mar; 28(3):295-300. PubMed ID: 18294108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination effects of baicalein with antibiotics against oral pathogens.
    Jang EJ; Cha SM; Choi SM; Cha JD
    Arch Oral Biol; 2014 Nov; 59(11):1233-41. PubMed ID: 25129811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro inhibition of coagulase-negative staphylococci by vancomycin/aminoglycoside-loaded cement spacers.
    Streuli JC; Exner GU; Reize CL; Merkofer C; Scott CP; Zbinden R
    Infection; 2006 Apr; 34(2):81-6. PubMed ID: 16703297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activity of calozeyloxanthone isolated from Calophyllum species against vancomycin-resistant Enterococci (VRE) and synergism with antibiotics.
    Sakagami Y; Kajimura K; Wijesinghe WM; Dharmaratne HR
    Planta Med; 2002 Jun; 68(6):541-3. PubMed ID: 12094300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase.
    Chan BC; Ip M; Lau CB; Lui SL; Jolivalt C; Ganem-Elbaz C; Litaudon M; Reiner NE; Gong H; See RH; Fung KP; Leung PC
    J Ethnopharmacol; 2011 Sep; 137(1):767-73. PubMed ID: 21782012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro synergistic antimicrobial effect of imipenem and colistin against an isolate of multidrug-resistant Enterobacter cloacae.
    Lin KH; Chuang YC; Lee SH; Yu WL
    J Microbiol Immunol Infect; 2010 Aug; 43(4):317-22. PubMed ID: 20688292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic activity of vancomycin and teicoplanin alone and in combination with streptomycin against Enterococcus faecalis strains with various vancomycin susceptibilities.
    Babalola CP; Patel KB; Nightingale CH; Nicolau DP
    Int J Antimicrob Agents; 2004 Apr; 23(4):343-8. PubMed ID: 15081082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of vancomycin-resistant enterococci isolates from human, poultry and pigs in Korea.
    Seo KS; Lim JY; Yoo HS; Bae WK; Park YH
    Vet Microbiol; 2005 Apr; 106(3-4):225-33. PubMed ID: 15778028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.